Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest minimal change disease Stories

2013-11-22 08:23:12

-- Company recognized at NephCure annual "Countdown for a Cure" fundraiser ANAHEIM, Calif., Nov. 22, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that the company has been recognized with an "Everyday Hero" award from the NephCure Foundation for its "tireless efforts" to advance science and research in the field of nephrology and to also promote educational efforts related to the treatment of proteinuria in patients with kidney disease who are suffering...

2012-01-16 13:09:00

ANAHEIM, Calif., Jan. 16, 2012 /PRNewswire/ -- On January 9, 2012, Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) received a communication from an individual representing herself to be associated with a website identified as StreetSweeper.org ("StreetSweeper"). The individual requested that the Company provide responses to a series of questions about the Company by January 10, 2012. Due to management's schedule, the individual was offered an opportunity to have the questions...

2010-12-13 13:08:56

University of Alabama at Birmingham researchers have pinpointed a protein that compromises the kidney's filtering ability, causing nephrotic syndrome, and demonstrated that a naturally occurring precursor of an acid in the body offers potential for treating some forms of the condition. The research was published online Dec. 12 in Nature Medicine. "This is a major breakthrough in understanding the development and treatment of kidney disease associated with proteinuria, the leakage of protein...